Cassava Sciences (SAVA) stock falls as the company halts Alzheimer's drug program after trial failures. Read more here.
Poppi unveils new formulation. Poppi. Poppi’s massive growth over the last few years has come with loyal fans, viral moments, ...
Cassava Sciences will discontinue its potential Alzheimer's treatment after recent trials showed no improvement to cognitive or functional decline. Shares halted from trading ahead of the morning bell ...
A research team investigates how genome editing can be harnessed to accelerate cassava breeding and improve key traits.
Poppi first gained widespread attention when it was featured on "Shark Tank" in 2018. Now the prebiotic soda is being bought ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback